GERON CORP's ticker is GERN and the CUSIP is 374163103. A total of 185 filers reported holding GERON CORP in Q3 2022. The put-call ratio across all filers is 0.16 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $48,285,987 | -29.5% | 22,776,409 | +6.7% | 3.73% | -28.7% |
| Q2 2023 | $68,526,560 | +47.9% | 21,347,838 | 0.0% | 5.23% | +63.4% |
| Q1 2023 | $46,324,808 | +17.3% | 21,347,838 | +30.8% | 3.20% | +44.3% |
| Q4 2022 | $39,491,208 | +3.4% | 16,318,681 | 0.0% | 2.22% | +16.4% |
| Q3 2022 | $38,186,000 | +51.0% | 16,318,681 | 0.0% | 1.91% | +46.7% |
| Q2 2022 | $25,294,000 | +14.0% | 16,318,681 | 0.0% | 1.30% | +102.7% |
| Q1 2022 | $22,193,000 | +35.1% | 16,318,681 | +21.2% | 0.64% | +93.1% |
| Q4 2021 | $16,423,000 | -10.9% | 13,461,538 | 0.0% | 0.33% | +51.6% |
| Q3 2021 | $18,442,000 | -2.8% | 13,461,538 | 0.0% | 0.22% | -11.3% |
| Q2 2021 | $18,981,000 | -10.8% | 13,461,538 | 0.0% | 0.25% | -48.2% |
| Q1 2021 | $21,269,000 | -0.6% | 13,461,538 | 0.0% | 0.48% | -15.6% |
| Q4 2020 | $21,404,000 | -8.6% | 13,461,538 | 0.0% | 0.56% | -43.0% |
| Q3 2020 | $23,423,000 | – | 13,461,538 | – | 0.99% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TCG Crossover Management, LLC | 23,375,839 | $49,556,779 | 7.30% |
| MPM BioImpact LLC | 10,712,481 | $22,710,460 | 6.06% |
| Ally Bridge Group (NY) LLC | 2,221,639 | $4,709,875 | 5.53% |
| Vivo Capital, LLC | 16,524,634 | $35,032,224 | 3.84% |
| NEA Management Company, LLC | 22,776,409 | $48,285,987 | 3.73% |
| Deep Track Capital, LP | 25,700,000 | $54,484,000 | 2.10% |
| RA Capital Management | 46,202,425 | $97,949,141 | 1.93% |
| Velan Capital Investment Management LP | 778,500 | $1,650,420 | 1.33% |
| Opaleye Management Inc. | 1,915,000 | $4,059,800 | 1.32% |
| Nan Fung Group Holdings Ltd | 753,550 | $1,597,526 | 1.29% |